We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current SRPT market cap is 10.98B. The company's latest EPS is USD -5.7107 and P/E is -20.48.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 230.27M | 258.43M | 253.5M | 261.24M | 331.82M |
| Operating Income | -131.36M | -106.83M | -138.09M | -133.52M | -20.84M |
| Net Income | -257.74M | -109.24M | -516.76M | -23.94M | -40.94M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 380.83M | 540.1M | 701.89M | 933.01M | 1.24B |
| Operating Income | -705.56M | -564.16M | -459.71M | -536.2M | -267.82M |
| Net Income | -715.08M | -554.13M | -418.78M | -703.49M | -535.98M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 3.16B | 3.13B | 3.06B | 3.13B | 3.11B |
| Total Liabilities | 2.73B | 2.74B | 2.35B | 2.38B | 2.35B |
| Total Equity | 430.84M | 384.95M | 712.75M | 741.41M | 764.36M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.82B | 2.98B | 3.15B | 3.13B | 3.26B |
| Total Liabilities | 1B | 2.22B | 2.22B | 2.74B | 2.41B |
| Total Equity | 818.19M | 761.76M | 928.01M | 384.95M | 859.34M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -232.95M | -325.35M | -209.4M | -331.63M | -446.34M |
| Investing | -1.06B | -1.05B | 12.49M | 109.13M | -101.45M |
| Financing | 221.76M | 232.51M | 101.8M | 107.66M | 123.06M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -456.46M | 107.47M | -443.17M | -325.35M | -500.99M |
| Investing | 286.73M | -121.72M | 495.41M | -1.05B | -165.8M |
| Financing | 642.55M | 682.32M | 561.57M | 232.51M | 125M |
| Market Cap | 10.98B |
| Price to Earnings Ratio | -20.48 |
| Price to Sales Ratio | 8.83 |
| Price to Cash Ratio | 25.62 |
| Price to Book Ratio | 12.77 |
| Dividend Yield | - |
| Shares Outstanding | 93.86M |
| Average Volume (1 week) | 630.02k |
| Average Volume (1 Month) | 623.62k |
| 52 Week Change | -8.03% |
| 52 Week High | 159.89 |
| 52 Week Low | 55.25 |
| Spread (Intraday) | 17.86 (13.97%) |
| Company Name | Sarepta Therapeutics Inc New |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.sarepta.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
